PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate Cancer

被引：0
|
作者：
Murphy, Declan G. [1 ,2 ]
Emmett, Louise [3 ]
机构：
[1] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[3] St Vincents Hosp, Dept Theranost & Nucl Med, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2024.06.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3
引用
收藏
页码：642 / 645
页数：4
相关论文
共 50 条
  • [21] 68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high-risk prostate cancer.
    Heidenreich, Axel
    Schmautz, Maximilian
    Pfister, David A.
    Hartmann, Florian
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [22] The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer
    Obek, Can
    Doganca, Tunkut
    Demirci, Emre
    Ocak, Meltem
    Kural, Ali Riza
    Yildirim, Asif
    Yucetas, Ugur
    Demirdag, Cetin
    Erdogan, Sarper M.
    Kabasakal, Levent
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (11) : 1806 - 1812
  • [23] The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer
    Can Öbek
    Tünkut Doğanca
    Emre Demirci
    Meltem Ocak
    Ali Rıza Kural
    Asıf Yıldırım
    Uğur Yücetaş
    Çetin Demirdağ
    Sarper M. Erdoğan
    Levent Kabasakal
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1806 - 1812
  • [24] 68Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer
    Kuten, Jonathan
    Mabjeesh, Nicola J.
    Lerman, Hedva
    Levine, Charles
    Barnes, Sophie
    Even-Sapir, Einat
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (02): : 100 - 104
  • [25] Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit
    Maestroni, Umberto Vittorio
    Campobasso, Davide
    Guarino, Giulio
    Acampora, Anna
    Scarlattei, Maura
    Ziglioli, Francesco
    Dinale, Francesco
    Baldari, Giorgio
    Migliari, Silvia
    Gasparro, Donatello
    Ferretti, Stefania
    Silini, Enrico Maria
    Ruffini, Livia
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (03)
  • [26] The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (01) : 1 - 2
  • [27] 68Ga-PSMA PET/CT in Preoperative Staging of Intermediate and High Risk Prostate Cancer Patients
    Schiller, C.
    Beheshti, M.
    Geinitz, H.
    Aschacher, B.
    Moinfar, F.
    Broinger, G.
    Pallwein-Prettner, L.
    Loidl, W.
    Langsteger, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S167 - S167
  • [28] Performance of PSMA PET for Staging of Prostate Cancer
    Guner, A.
    Unal, K.
    Temiz, H.
    Kaya, E.
    Vardareli, E.
    Tuna, M.
    Doganca, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S605 - S605
  • [29] Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
    Daniela A. Ferraro
    Helena I. Garcia Schüler
    Urs J. Muehlematter
    Daniel Eberli
    Julian Müller
    Alexander Müller
    Roger Gablinger
    Helmut Kranzbühler
    Aurelius Omlin
    Philipp A. Kaufmann
    Thomas Hermanns
    Irene A. Burger
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 652 - 664
  • [30] Clinical value of 18F-PSMA-1007 PET/MRI in primary staging of patients with intermediate- to high-risk prostate cancer
    Ali, Ismail
    Rezk, Mahmoud
    Hamouda, Dalia
    Talaat, Omnia
    Omar, Yehia
    Abdel Tawab, Mohamed
    Nasr, Ibrahim
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1155): : 622 - 631
12345